Pressure BioSciences Inc. (PBIO)
|Net Income (ttm)||-16.91M|
|Trading Day||February 26|
|Day's Range||2.06 - 2.49|
|52-Week Range||1.19 - 4.49|
There are no news available yet.
Pressure BioSciences develops pressure cycling technology (PCT) solutions in North America, Europe, and Asia. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations, including Barocycler 2320EXT, Barozyme-HT48, Barocycler HUB440, and The Shredder SG3. It also distributes cell disruption equipment, parts, and consumab... [Read more...]
|IPO Date |
Oct 31, 1996
Richard T. Schumacher
|Stock Exchange |
|Ticker Symbol |
In 2019, PBIO's revenue was $1.81 million, a decrease of -26.36% compared to the previous year's $2.46 million. Losses were -$11.66 million, 20.2% more than in 2018.
The average 12-month stock price forecast for PBIO is 1.57, which is a decrease of -31.74% from the latest price.